This wiki has undergone a migration to Confluence found Here
Difference between revisions of "Supplemental New Drug Application"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
A Supplemental New Drug Application is an application that when approved will allow a company to make changes in a product that already has an approved new drug application (NDA). | A Supplemental New Drug Application is an application that when approved will allow a company to make changes in a product that already has an approved new drug application (NDA). | ||
| + | ==Additional Regional Definitions and Synonyms== | ||
| + | ''None'' | ||
| + | |||
| + | [[Category:RPS Glossary]] | ||
Latest revision as of 19:03, 26 September 2008
A Supplemental New Drug Application is an application that when approved will allow a company to make changes in a product that already has an approved new drug application (NDA).
Additional Regional Definitions and Synonyms
None
